LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that Safi Bahcall, Ph.D., President and CEO, will discuss the Company’s oncology and inflammation drug discovery and development programs and provide a general corporate overview at the upcoming BIO CEO & Investor Conference, to be held at the Waldorf Astoria Hotel in New York City. The presentation will begin at 2:00 p.m. (EST) on Monday, February 12, 2007, and will be located in the Park Avenue Suite Center/North.
